Observing outcomes of the Medacta Shoulder System
Official title: Clinical and Radiological Outcomes of Medacta Shoulder System
Run by Medacta International SA · NCT05926622 · Data updated 2026-11-12
This study is looking at how well the Medacta Shoulder System works and its safety for people with different shoulder problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Medacta International SA Industry-sponsored |
| Locations | 1 site (Annecy) |
| Status | Recruiting |
| Started | March 15, 2022 |
| Main results expected | March 2032 |
| Study ends | March 2037 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT05926622 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with specific shoulder diagnoses such as osteoarthritis or rotator cuff tear arthropathy.
✕Probably not a fit
Patients with malignant diseases, infections, or other significant functional deficits unrelated to the shoulder may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the clinical and radiological outcomes of the Medacta Shoulder System in patients with various shoulder conditions. It aims to gather data on the effectiveness and safety of this shoulder implant in real-world settings. The study will include patients diagnosed with primary and secondary osteoarthritis, rotator cuff tear arthropathy, rheumatoid arthritis, and other shoulder-related conditions. By monitoring these outcomes, the study seeks to provide insights into the long-term performance of the shoulder system.
Why it matters
Potential benefit: If successful, this study could enhance understanding of shoulder implant effectiveness, leading to improved treatment options for patients with shoulder conditions.
How similar studies have gone: While this study is observational and focuses on a specific implant, similar studies have shown success in evaluating the outcomes of shoulder arthroplasties.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than 18 years * Patient with one of the following diagnosis: Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty Exclusion Criteria: * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)
Where it's running
-
Clinique Générale Annecy
Annecy, France Recruiting
Study contacts
- Principal investigator: Bruno Toussaint — Clinique Générale Annecy
- Study coordinator: Arianna Girardi
- Email: girardi@medacta.ch
- Phone: +41 91 696 60 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term follow-up on shoulder arthroplasty outcomes
This study is looking at how well shoulder replacement surgery works over time by following patients for at least 10 years to see how they feel and how their shoulders are doing.
-
Evaluation of the PERFORM™ Humeral System for shoulder conditions
This study is testing how safe and effective the PERFORM™ Humeral System is for people who have had shoulder surgery by tracking their recovery and quality of life over the next ten years.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
Tipmed Shoulder Prosthesis PMCF: safety and outcomes after shoulder replacement
This PMCF study tests the safety and function of the Tipmed shoulder prosthesis in adults undergoing reverse shoulder or hemiarthroplasty in real-world practice.
-
See how well iFuse TORQ TNT works for pelvic fragility fractures
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.